
Spartan Race has announced it has an exclusive option to acquire Tough Mudder’s UK, Canadian, and German events in a deal that would herald the merger of the two leading entities in the obstacle course racing market.
US-based Spartan Race stated that under the proposed deal, Tough Mudder events in the three countries will continue to be operated by the same team and under the same brand, but will be part of the larger Spartan family of brands and events.
“This is a goal we’ve had for some time,” Spartan chief executive and founder Joe De Sena said in a statement. “Tough Mudder UK, Canada, and Germany bring a unique experience, and putting the success of the two together strengthens our global mission of getting 100 million people off the couch.”
Under Spartan ownership, the company stated Tough Mudder UK, Canada, and Germany events will be focused as “teamwork-based, non-competitive festival events.” The competitions will be handled by Spartan.
Spartan stated it will continue to work with Tough Mudder’s founders, Will Dean and Guy Livingstone, in efforts to complete the acquisition and renewal of Tough Mudder’s US-based events and operations. De Sena added, “I look forward to creating a lasting partnership with Will and Guy as we seek to complete the merger. I’m excited about the prospect of what we can do together, as one team.”
Full Content: Endurance Business
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas